Form 4: Repligen Corp Executive Olivier Loeillot Reports Acquisition of Shares and Stock Options
SEC Form 4 Filing
Olivier Loeillot, President and CCO of Repligen Corp, reports the acquisition of 2,880 shares of common stock and 2,860 stock options.
Summary
- On February 27, 2024, Olivier Loeillot, President and CCO of Repligen Corporation, acquired 2,880 shares of common stock and 2,860 stock options.
- The 2,880 shares were awarded as restricted stock units, each representing a contingent right to receive one share of Repligen's common stock.
- These restricted stock units vest in equal annual installments over three years, starting on the first anniversary of the grant date.
- The stock options, with an exercise price of $192.71, vest annually over three years, beginning February 27, 2025.
- Following these transactions, Loeillot directly owns 15,786 shares of Repligen's common stock and 2,860 stock options.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard regulatory filing detailing executive compensation. The acquisition of shares and options could be seen as a positive signal, but it's a routine event.
Positives
- The acquisition of shares and stock options by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The restricted stock units vest annually over three years, and the stock options also vest annually over three years starting February 27, 2025.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company executives and their holdings in the company's stock.
Comparison to Industry Standards
- Insider transactions are a normal part of executive compensation in publicly traded companies like Repligen.
- Companies such as Danaher, Thermo Fisher Scientific, and Sartorius also regularly report similar Form 4 filings for their executives.
- The vesting schedules for the restricted stock units and stock options are typical for executive compensation packages.
Stakeholder Impact
- Shareholders may view the executive's increased stake in the company as a positive sign of confidence.
- Employees may see this as a reflection of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 02/27/2024 | Date of transaction: Acquisition of common stock and stock options. |
| 02/27/2025 | First vesting date for one-third of the stock options. |
| 02/27/2026 | Second vesting date for one-third of the stock options. |
| 02/27/2027 | Third vesting date for one-third of the stock options. |
| 02/27/2034 | Expiration date for the stock options. |
| 02/29/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.